The PI3K/AKT pathway is one of the most prevalent dysregulated signaling pathways in cancer patients, which exerts a critical effect on promoting tumorigenesis, progression and therapeutic response as well as the EMT process (Wang et al., 2023; Mo et al., 2023; Wei, Chen & Feng, 2023). This evidence concerns the gene AKT1 and cancer.